Explore comprehensive CDMO services offered by Hillgene Biopharma Co Ltd, supporting end-to-end Anlaytical Testing, Drug Development and Manufacturing. Hillgene Biopharma Co Ltd enables faster, compliant, and scalable pharma innovation tailored to your needs.
Country: China
Description: Hillgene Biopharma Co. Ltd. is a Chinese Contract Development and Manufacturing Organization (CDMO) that specializes in cell therapy, including CAR-T, TCR-T, and CAR-NK therapies. Headquartered in Suzhou, China, it provides end-to-end services from research to manufacturing, with facilities in Suzhou and Shenzhen and a planned expansion into the U.S. in North Carolina. Key services include lentiviral vector production, nucleic acid manufacturing, and process development for cell-based therapies.
